FDBusiness.com

New Research by Nestle Health Science to Help Improve Inflammatory Bowel Disease Treatment

 Breaking News
  • Ebro Expands in Pasta With €130 Million Deal Spanish food group Ebro has agreed to acquire a 70% stake in Bertagni 1882, the Italian premium fresh pasta producer, for €130 million. With production plants in Vicenza and Avio in Italy, Bertagni employs 275 people and is known as the oldest brand of filled pasta in Italy. Its gross sales in 2017 will exceed [...]...
  • 100% Green Distillery to Open in Yorkshire A Yorkshire-based gin and whisky distillery is one of only three in England to be run solely on green energy. As England’s smallest and first self-built whisky and gin distillery, Cooper King Distillery will commence production of its juniper-led gin and open its doors to members of the public this spring, the whisky distillation will follow [...]...
  • ULMA Packaging’s Flexible Solution Helps Make Dairy’s Day Dairy Day, a Watford-based specialist in artisan cheeses, has reported a significant increase in production since replacing a manual packing machine with ULMA Packaging Ltd’s TFS 200 Thermoformer – providing the family-run business with the extra capacity it needed to meet the increasing demand from retailers and foodservice customers for its handmade halloumi cheese. Investing in a packaging system is [...]...
  • Wavegrip Introduces New Service WaveGrip, manufacturer of innovative beverage multi-packaging solutions, has launched a dedicated machine manufacturing and engineering support service. Combining all WaveGrip automation, engineering and global servicing capabilities, including its OEM partners, the new WaveTec service will ensure WaveGrip Applicators continue to deliver the best performance to support companies’ multi-packing needs. WaveTec will also give all WaveGrip customers [...]...
  • Riggs Autopack Ltd – British Manufacturer of Depositors & Filling Machines For Food Production Riggs Autopack is a British manufacturer of high quality depositors and filling machines, transfer pumps and automatic conveyor filling lines. They are a UK market leader with an excellent reputation and supply their equipment to the food production industry. Their Model 1000 volumetric depositors and filling machines are one of the most precise and hygienic on [...]...

New Research by Nestle Health Science to Help Improve Inflammatory Bowel Disease Treatment

New Research by Nestle Health Science to Help Improve Inflammatory Bowel Disease Treatment
May 24
11:52 2012

Prometheus Laboratories, a company acquired by Nestle Health Science, has presented new research that confirms the effectiveness of its new diagnostic test designed to improve treatment management for patients with inflammatory bowel disease (IBD). The test is designed to predict inflammatory bowel disease activity and measure the impact of infliximab, a drug used by patients to help prevent inflammation.

Over time, some of them become less responsive to the drug so it is vital for medical practitioners to be able to diagnose this early on so a different course of treatment can be found. The data, reported by the company at this year’s Digestive Disease Week event in San Diego, in the United States, provides evidence of the effectiveness of the company’s new monitoring test which will be launched later this year.

Nestle Health Science acquired Prometheus Laboratories mid 2011. Prometheus specialises in diagnostics and in-licensed specialty pharmaceuticals in gastroenterology and oncology and focuses on conditions such as IBD.

The test should help ensure patients with chronic inflammatory bowel disorders can be treated effectively. These include ulcerative colitis and Crohn’s disease which typically cause abdominal pain, fever and diarrhoea.

IBD is clinically difficult to diagnose and manage, with many patients requiring long term medical care. Currently the disease has no cure.  Recent statistics from the Crohn’s and Colitis Foundation of America estimate that about 1.4 million people in the country suffer from the disease.

The new research into how to manage IBD supports Nestlé Health Science’s long-term vision and ambition to develop science-based personalised nutritional solutions. The company, established last year, is a wholly-owned subsidiary of Nestlé.

Building on its core HealthCare Nutrition business, Nestlé Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or special challenges of different life stages. Nestlé Health Science has access to external scientific and technological know-how through Nestlé’s innovation network as well as a number of venture capital funds in which the group has interests.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • January 19, 2018International Green Week
  • January 20, 2018Sigep Rimini
  • January 24, 2018International Bulk Wine and Spirits Show (IBWSS)
  • January 28, 2018ProSweets Cologne (Int'l Sweets and Biscuits Fair)
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements